Precisense A/S is a Danish A/S based in København Ø, operating in the Forskning og eksperimentel udvikling indenfor bioteknologi sector. Incorporated in 1995.
45,4 mio. kr.
+306% vs 2013
Solidity ratio Equity ÷ Total assets × 100 2012 2014
Liquidity ratio Current assets ÷ Short-term debt 2012 2014
Return on assets (ROA) Net profit ÷ Total assets × 100 2012 2014
EBITDA — year on year DKK millions 67M 39M 12M -16M -44M 2012: 0M 0M 2012 2013: -22M -22M 2013 2014: 45M (+305% vs 2013) 45M +305% 2014
Key figures Annual report 2014 Revenue — — EBITDA 45,4 mio. kr. +306% Net profit 45,4 mio. kr. +306% Total assets 0 mio. kr. -7% Equity 0 mio. kr. +100% Employees — —
Founded
10 March 1995 · 31 years
Share capital
DKK 86.636.572
Financial year
January – December
Signatory rights
Selskabet tegnes af likvidator.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development The figures on this page draw on 3 annual filings covering 2012 to 2014. The bottom line showed a net profit of 45,4 mio. kr..
At the end of 2014, equity financed 0% of the balance sheet, and current assets covered short-term debt 1 times.
Frequently asked questions What is the CVR number of Precisense A/S? Precisense A/S is registered with CVR / Virk under CVR 18445573.
Where is Precisense A/S headquartered? Precisense A/S's registered address is Lautrupsgade 7, 5..
